From: Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome
n | Age | BMI | FPG (mmoL/L) | FINS (mU/L) | HOMA-IR | PRX3 (ng/ml) | |
---|---|---|---|---|---|---|---|
Control-IRL -Lean | 28 | 29.6 ± 4.4 | 20.9 ± 3.3 | 5.3 ± 0.5 | 7.7 ± 0.6 | 1.8 ± 0.1 | 29.8 ± 3.4 |
t values | 0.397 | 7.534 | 2.580 | 7.961 | 4.962 | 0.156 | |
P values | 0.695 | < 0.001a | 0.02a | < 0.001a | < 0.001a | 0.877 | |
PCOS-IRH -Obese | 22 | 29.3 ± 3.0 | 31.4 ± 3.1 | 6.7 ± 1.5 | 29.3 ± 10.5 | 9.2 ± 5.2 | 30.4 ± 3.6 |
t values | −1.093 | 4.315 | 2.661 | 6.001 | 4.646 | 1.154 | |
P values | 0.293 | 0.001a | 0.02a | < 0.001a | 0.001a | 0.268 | |
PCOS-IRL -Lean | 10 | 31 ± 2.6 | 24.8 ± 2.0 | 5.3 ± 0.4 | 9.0 ± 2.6 | 1.9 ± 0.5 | 25.1 ± 2.7 |